| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.medicointercontinental.com | |
| Market Cap | 45.11 Cr. | |
| Enterprise Value(EV) | 50.94 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.93 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 11.49 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 63.82 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 44.00 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.03 | Calculated using Price: 45.11 |
| Dividend Yield | 0.22 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.00 Cr. | 10,000,000 Shares |
| FaceValue | 10 | |
| About Medico Intercontinental Ltd. | ||
| Medico Intercontinental Limited formerly Intercontinental Leasing & Finance Company Limited was incorporated on August 14, 1984. The Company is into the business of trading various medicines. The company also provides a platform to all research based biopharmaceutical companies reaching their Novel and innovative therapies. | ||
| 1 Day |
|
-1.89% |
| 1 Week |
|
-9.45% |
| 1 Month |
|
-13.57% |
| 3 Month |
|
-59.20% |
| 6 Month |
|
-46.07% |
| 1 Year |
|
-43.55% |
| 2 Year |
|
-24.82% |
| 5 Year |
|
-56.20% |
| 10 Year |
|
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.9 | 20.24 | 45.48 | 32.41 | 27.96 | 13.41 | |
| Return on Capital Employed (%) | 1.41 | 28.42 | 36.08 | 25 | 25.69 | 16.57 | |
| Return on Assets (%) | 0.76 | 11.32 | 10.44 | 7.73 | 9.91 | 7.95 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 3 | 4 | 6 | 10 | 13 | 41 | 43 | |
| Non Curr. Liab. | 0 | 13 | 7 | 6 | 2 | 3 | ||
| Curr. Liab. | 1 | 5 | 17 | 15 | 13 | 15 | 11 | |
| Minority Int. | ||||||||
| Equity & Liab. | 4 | 9 | 36 | 31 | 32 | 59 | 57 | |
| Non Curr. Assets | 2 | 1 | 2 | 3 | 4 | 9 | 15 | |
| Curr. Assets | 2 | 8 | 34 | 28 | 28 | 50 | 42 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 4 | 9 | 36 | 31 | 32 | 59 | 57 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 10 | 82 | 70 | 74 | 76 | 85 | ||
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Total Income | 0 | 10 | 82 | 70 | 75 | 77 | 85 | |
| Total Expenditure | 0 | -9 | -78 | -65 | -69 | -71 | -79 | |
| PBIDT | 0 | 1 | 4 | 5 | 5 | 6 | 6 | |
| Interest | 0 | -1 | -1 | -1 | -1 | 0 | ||
| Depreciation | 0 | 0 | 0 | 0 | 0 | |||
| Taxation | 0 | 0 | -1 | -1 | -1 | -1 | -2 | |
| Exceptional Items | ||||||||
| PAT | 0 | 1 | 2 | 3 | 3 | 4 | 4 | |
| Minority Interest | ||||||||
| Share Associate | ||||||||
| Other Related Items | ||||||||
| Consolidated Net Profit | 0 | 1 | 2 | 3 | 3 | 4 | 4 | |
| Adjusted EPS | 0 | 2 | 7 | 8 | 10 | 4 | 4 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 1 | -14 | 6 | 4 | -10 | |
| Cash Fr. Inv. | -4 | -1 | -1 | -5 | |||
| Cash Fr. Finan. | 0 | 17 | -5 | -1 | 20 | ||
| Net Change | 0 | 1 | 0 | 0 | 1 | 5 | |
| Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 2 | 7 |
|
Tue, 09 Apr 2024
Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. April 09 2024 inter alia considered and approved investing Company funds by way of infusing initial capital of Rs. 50 000/- i.e. holds 50% stake in proposed partnership firm having the same business segment i.e. pharmaceutical segment. |
|
Tue, 09 Apr 2024
Announcement under Regulation 30 (LODR)-Meeting Updates Outcome of Board Meeting and Compliances of Regulation 30 of SEBI LODR 2015. |
|
Mon, 08 Apr 2024
Compliances - PCS Certificate As On 31.03.2024 Submission of Compliance Certificate pursuant to Reg. 40(9) of SEBI LODR 2015 issued by PCS for the financial year ended 31.03.2024. |
| Tue, 16 Apr 2024 |
Opening at Low
|
Closing Below Previous Low
|
Closing Below Previous Low for 3 days
|
Making Lower Lows for 3 days
|
Closing Below Previous Low for 2 Days
|
